Rhaeos

company

About

Rhaeos is a clinical stage medical device company.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.19M
Industries
Biotechnology,Education,Health Care,Health Diagnostics,Medical,Medical Device,Neuroscience,Sensor,Wearables
Founded date
May 14, 2018
Number Of Employee
1 - 10
Operating Status
Active

Rhaeos, the world's first wearable shunt monitor, aims to improve the quality care for patients with hydrocephalus through a novel, thermal biosensor. Developed within Northwestern University with collaboration between Dr. John Rogers, McCormick School of Engineering, Feinberg School of Medicine and Kellogg School of Management, Rhaeos represents a unique multidisciplinary translational effort for an important clinical need.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.44M
Rhaeos has raised a total of $1.44M in funding over 2 rounds. Their latest funding was raised on Feb 18, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 18, 2021 Grant $1.19M 1 National Science Foundation Detail
Nov 25, 2019 Grant $250K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Rhaeos is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant